TO STUDY THE EFFECTIVENESS OF HOMOEOPATHIC MEDICINES IN POLYCYSTIC OVARIAN SYNDROME

A PROSPECTIVE INTERVENTIONAL STUDY TO EXPLORE THE EFFICACY OF HOMOEOPATHIC MEDICINES IN REDUCING THE OVARIAN VOLUME IN POLYCYSTIC OVARIAN SYNDROME

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/11/022187

Enrollment

Registered

2019-11-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: HOMOEOPATHIC MEDICINES: INDIVIDUALISED HOMOEOPATHIC MEDICINES AS PER HOMOEOPATHIC PRINCIPLES POTENCIES 30C TO 50 M WILL BE SELECTED REPEATED ACCORDING TO NEED OF THE PATIENT FOR 1 YEAR

Eligibility

Inclusion criteria

Inclusion criteria: Women Among Reproductive Age Group HavingPolycystic Ovarian Syndrome With Ovarian Volume Greater Than 10cc In Any One Of The Ovaries

Exclusion criteria

Exclusion criteria: Cases Having Endocrinal Abnormalities Similar To Polycystic Ovarian Syndrome Type 2 Diabetes Mellitus Taking Metformin Tablets Pregnant And Lactating Mothers

Design outcomes

Primary

Measure	Time frame
Reduction In Ovarian Volume After Homoeopathic Intervention Is Considered To Be SignificantTimepoint: 1 YEAR FOLLOW UP	—

Secondary

Measure	Time frame
Changes In Insulin Resistance Changes in Number Of Peripherally Arranged Cysts In Ovaries Changes In BMI And Waist hip RatioTimepoint: 1 YEAR FOLLOW UP	—

Countries

India

Contacts

Public ContactDR R SITHARTHAN

NATIONAL HOMOEOPATHY RESEARCH INSTITUTE IN MENTAL HEALTH

sitharthan.r@gmail.com9443203174

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026